CareDx Inc
Ownership
Ownership Structure
Who owns CareDx Inc (CDNA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.6% of the shares are freely tradable; institutional investors hold 101.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.74 | 4,522,096 | -2.8 | 03/31/2026 |
| BAMCO Inc | 6.45 | 3,336,409 | +5.7 | 03/31/2026 |
| State Street Corp | 5.34 | 2,760,385 | +0.8 | 03/31/2026 |
| ARK Investment Management LLC | 4.31 | 2,227,556 | +4.3 | 03/31/2026 |
| Deerfield Management Co | 4.24 | 2,191,000 | +0.0 | 03/31/2026 |
| BRAIDWELL LP | 4.20 | 2,173,146 | +37.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.18 | 2,160,457 | +0.0 | 03/31/2026 |
| Boston Partners Global Investors, Inc | 3.75 | 1,937,601 | +2.9 | 06/30/2026 |
| Gagnon Securities LLC | 3.42 | 1,770,735 | +0.5 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Genomic Revolution | 3.56 | 1,841,327 | -12.7 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Hanna John Walter JR | President and CEO | 653,448 | 35,482,226 $ | Jul 16, 2026 | direct |
| Kennedy Keith | CFO & COO | 211,704 | 11,495,527 $ | Sep 12, 2026 | direct |
| Meng Jessica | Chief Commercial Officer | 161,599 | 8,774,826 $ | Sep 12, 2026 | direct |
| Bickerstaff George | Director | 134,061 | 7,279,512 $ | Aug 5, 2026 | direct |
| Novack Jeffrey Adam | Secretary and General Counsel | 106,075 | 5,759,873 $ | Aug 5, 2026 | direct |
| Goldberg Michael | Director | 61,738 | 3,352,373 $ | Aug 4, 2026 | direct |
| Cournoyer Christine | Director | 42,943 | 2,331,805 $ | Aug 4, 2026 | direct |
| Valantine Hannah | Director | 36,686 | 1,992,050 $ | Jul 16, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 12, 2026 | Meng Jessica | Chief Commercial Officer | Other | 6,688 | 52.37 | 350,251 |
| Sep 12, 2026 | Kennedy Keith | CFO & COO | Other | 8,220 | 52.37 | 430,481 |
| Aug 5, 2026 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | 500 | 46.75 | 23,375 |
| Aug 5, 2026 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | 2,188 | 46.15 | 100,974 |
| Aug 5, 2026 | Bickerstaff George | Director | Sell | 20,000 | 46.29 | 925,700 |
| Aug 4, 2026 | Goldberg Michael | Director | Sell | 44,700 | 47.06 | 2,103,497 |
| Aug 4, 2026 | Cournoyer Christine | Director | Sell | 16,000 | 46.94 | 750,973 |
| Aug 1, 2026 | Novack Jeffrey Adam | Secretary and General Counsel | Other | 2,872 | 47.85 | 137,425 |
| Jul 16, 2026 | Valantine Hannah | Director | Sell | 100 | 36.55 | 3,655 |
| Jul 16, 2026 | Valantine Hannah | Director | Sell | 28,679 | 36.14 | 1,036,588 |
| Jul 16, 2026 | Valantine Hannah | Director | Other | 5,125 | 7.96 | 40,795 |
| Jul 16, 2026 | Valantine Hannah | Director | Other | 16,048 | 14.19 | 227,721 |
| Jul 16, 2026 | Valantine Hannah | Director | Other | 7,606 | 20.56 | 156,379 |
| Jul 16, 2026 | Hanna John Walter JR | President and CEO | Sell | 68,000 | 39.01 | 2,652,932 |
| Jul 16, 2026 | Hanna John Walter JR | President and CEO | Sell | 50,000 | 36.11 | 1,805,705 |
| Jul 16, 2026 | Hanna John Walter JR | President and CEO | Other | 118,000 | 8.20 | 967,600 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.